Concurrent chemoradiotherapy with weekly docetaxel versus cisplatin in the treatment of locoregionally advanced nasopharyngeal carcinoma: a propensity score-matched analysis

DOI: 10.1186/s40880-019-0380-x

Keywords: Concurrent chemoradiotherapy, Docetaxel, Cisplatin, Nasopharyngeal carcinoma, Propensity score matching, Intensity-modulated radiotherapy, Overall survival, Distant metastasis-free survival, Locoregional recurrence-free survival, Nodal recurrence-free survival

Full-Text   Cite this paper   Add to My Lib

Abstract:

The online version of this article (10.1186/s40880-019-0380-x) contains supplementary material, which is available to authorized users

Full-Text